Related Experiment Video
Updated: May 7, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Manganese exposure induces parkinsonism-like symptoms by Serpina3n-TFEB-v/p-ATPase signaling mediated lysosomal
Huihui Hong1, Sicheng Liu1, Ting Yang2
1Department of Environmental Medicine, School of Medicine, Chongqing University, Chongqing, China.
Abstract:
Manganese (Mn) is a neurotoxin that has been etiologically linked to the development of neurodegenerative diseases in the case of overexposure. It is widely accepted that overexposure to Mn leads to manganism, which has clinical symptoms similar to Parkinson's disease (PD), and is referred to as parkinsonism. Astrocytes have been reported to scavenge and degrade extracellular α-synuclein (α-Syn) in the brain. However, the mechanisms of Mn-induced neurotoxicity associated with PD remain unclear. Serpina3n is highly expressed in astrocytes and has been implicated in several neuropathologies. The role Serpina3n plays in Mn neurotoxicity and PD pathogenesis is still unknown. Here, we used wild-type and Serpina3n knockout (KO) C57BL/6 J mice with i.p. injection of 32.5 mg/kg MnCl2 once a day for 6 weeks to elucidate the role of Serpina3n in Mn-caused neurotoxicity regarding parkinsonism pathogenesis. We performed behavioral tests (open field, suspension and pole-climbing tests) to observe Mn-induced motor changes, immunohistochemistry to detect Mn-induced midbrain changes, and Western blot to detect Mn-induced changes of protein expression. It was found that Serpina3n KO markedly alleviated Mn neurotoxicity in mice by attenuating midbrain dopaminergic neuron damage and ameliorating motor deficits. Furthermore, using immunofluorescence colocalization analysis, Western blot and quantitative real-time PCR on Mn-treated C8-D1A cells, we found that Serpina3n KO significantly improved astrocytic α-Syn clearance by suppressing Mn-induced lysosomal dysfunction. Reduced transcription factor EB (TFEB)-v/p-ATPase signaling is responsible for the impairment of the lysosomal acidic environment. These novel findings highlight Serpina3n as a detrimental factor in Mn neurotoxicity associated with parkinsonism, capture the novel role of Serpina3n in regulating lysosomal function, and provide a potential target for antagonizing Mn neurotoxicity and curing parkinsonism in humans.
Insights
Manganese (Mn) overexposure causes parkinsonism. Removing Serpina3n protein in mice reduced Mn neurotoxicity and improved motor function by enhancing α-synuclein clearance and lysosomal function.
Area of Science:
- Neuroscience
- Toxicology
- Cell Biology
Background:
- Manganese (Mn) overexposure is linked to neurodegenerative diseases, causing parkinsonism with symptoms similar to Parkinson's disease (PD).
- Astrocytes clear extracellular α-synuclein (α-Syn), but Mn-induced neurotoxicity mechanisms, especially involving astrocyte-expressed Serpina3n, remain unclear.
- Serpina3n's role in Mn neurotoxicity and PD pathogenesis is unknown, necessitating investigation into its contribution to these conditions.
Purpose of the Study:
- To elucidate the role of Serpina3n in manganese neurotoxicity and parkinsonism pathogenesis.
- To investigate how Serpina3n influences astrocyte function, α-synuclein clearance, and lysosomal activity in the context of Mn exposure.
Main Methods:
- Utilized wild-type and Serpina3n knockout (KO) mice subjected to chronic manganese chloride (MnCl2) intraperitoneal injections.
- Conducted behavioral tests (open field, suspension, pole-climbing) to assess motor deficits.
- Employed immunohistochemistry, Western blot, immunofluorescence, and quantitative real-time PCR to analyze midbrain changes, protein expression, and cellular mechanisms.
Main Results:
- Serpina3n KO significantly alleviated Mn neurotoxicity, attenuating dopaminergic neuron damage and improving motor deficits in mice.
- Serpina3n deficiency enhanced astrocytic α-synuclein clearance by suppressing Mn-induced lysosomal dysfunction.
- Reduced transcription factor EB (TFEB)-v/p-ATPase signaling was identified as responsible for impaired lysosomal acidity in Mn-treated cells.
Conclusions:
- Serpina3n acts as a detrimental factor in manganese neurotoxicity contributing to parkinsonism.
- Serpina3n plays a novel role in regulating lysosomal function and α-synuclein clearance.
- Targeting Serpina3n presents a potential therapeutic strategy for counteracting manganese neurotoxicity and treating parkinsonism.
More Related Videos
Related Concept Videos
Lysosomal Hydrolases
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll

